This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: National Cancer Center, Tokyo University of Science Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Koji Okamoto: Innovator in Cancer Treatment
Introduction
Koji Okamoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Koji Okamoto holds a patent for a compound, production method therefor, and pharmaceutical composition. This compound is represented by a specific formula that is useful for treating cancer. The patent details a production method that enables the compound to be produced with high efficiency, along with a pharmaceutical composition containing the compound as an active ingredient. This innovation is crucial in the ongoing fight against cancer.
Career Highlights
Throughout his career, Okamoto has worked with esteemed institutions such as the Tokyo University of Science Foundation and the National Cancer Center. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Koji Okamoto has collaborated with notable colleagues, including Isamu Shiina and Motoyuki Shimonaka. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Koji Okamoto's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile